tiprankstipranks
Blurbs

WELL Health Technologies Corp (WELL) Receives a Buy from Echelon Wealth Partners

WELL Health Technologies Corp (WELLResearch Report), the Healthcare company was revisited today, and remains undervalued for at least one analyst on the street. Analyst Rob Goff from Echelon Wealth Partners remains bullish on the stock and has a C$8.00 price target.

Goff has an average return of 6.0% when recommending WELL Health Technologies Corp.

According to TipRanks.com, Goff is ranked #234 out of 8631 analysts.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for WELL Health Technologies Corp with a C$8.83 average price target, which is a 109.2% upside from current levels. In a report issued on November 9, Scotiabank also maintained a Buy rating on the stock with a C$6.50 price target.

Based on WELL Health Technologies Corp’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of C$171 million and GAAP net loss of C$5.77 million. In comparison, last year the company earned revenue of C$140 million and had a GAAP net loss of C$12.17 million.

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: Clinical services, Digital services, and others. It also engages in the Electronic Medical Records business that supports the digitization of clinics. Its objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health.

The company’s shares closed last Monday at C$4.32.

Read More on TSE:WELL:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles